ࡱ> fhe 0bjbj&W&W 4bD=D= (`````ttt88<t?rtttttY"Y"Y"???????$ACf4?`0$ Y"0$0$4?``tt= I?5550$F`pt`t?50$?55V~<@B=tɣv$< >_?0?<xD|%pDB=D`B=Y"L"65",#)Y"Y"Y"4?4?+ Y"Y"Y"?0$0$0$0$DY"Y"Y"Y"Y"Y"Y"Y"Y" &:        BEHAVIORAL HEALTHCARE PROGRAM OUTPATIENT TREATMENT REPORT Patient Information: Name:_____________________________________________________________ID#_________________________________DOB:_____________________ Provider Information: Name:__________________________________________________________________________________ Licensure Level:___________________________ Facility/Group: ______________________________________________________________Phone:______________________ Fax:______________________ Address:______________________________________________________City:____________________________State:___________Zip:________________ Diagnosis / Medical Issues (Responses to all questions are required) Medical Conditions: ___None ___Chronic Pain ___ Cancer___ Obesity___ Dementia ___Cardiovascular Issues ___Diabetes___ Asthma/COPD ___ Nicotine/Tobacco Use Other______________________________________________________ I have offered referral information/other health information regarding identified health issues to the patient as needed. Yes___ No___ Disorder(s) being treated: (Required) Primary/Secondary Diagnosis: (Please include Diagnosis Name, Diagnosis Code) ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ I have reviewed the relationship between medical /mental health issues with the patient. __Yes __No __N/A Symptoms/Symptom Reduction (Responses to all questions are required) Substance Use/Abuse: Is this patient being treated for substance abuse? ___Yes ___No Is the goal of treatment abstinence___ or harm reduction___ ? (Please mark the appropriate response) Is the patient abstinent? ___Yes ___No ___ Participating in self-help groups? ___Yes ___No ___N/A If not attending self help, have you developed other community supports for this patient? ___Yes ___No ___NA Please complete this section with your patient, collaborating on the report of progress based on symptom reduction for up to two identified symptoms as they relate to the treatment diagnosis. (1=least severe, 10=most severe) Symptom #1: ________________________________________________________________________________________ Severity at start of treatment: 1 2 3 4 5 6 7 8 9 10 Current severity: 1 2 3 4 5 6 7 8 9 10 Symptom #2: ________________________________________________________________________________________ Severity at start of treatment: 1 2 3 4 5 6 7 8 9 10 Current severity: 1 2 3 4 5 6 7 8 9 10 Patients overall level of impairment of functioning on admission (per DSM V): Mild_____ Moderate_____ Severe_____ Very Severe_____ Patients current overall level of impairment of functioning (per DSM V): Mild_____ Moderate_____ Severe_____ Very Severe_____ PHQ-9 Score (Adult Depressive Diagnosis Only): Baseline _____ Current _____ Is this patient at risk for self harm? Yes___ No___ If yes, is there a safety plan in place? Yes___ No___ Psychotropic Medications Dosage Prescriber ________________ Communication with Prescriber ____________________________________________________________________________________________________________________Yes No No Meds ____________________________________________________________________________________________________________________Yes No No Meds ____________________________________________________________________________________________________________________Yes No No Meds Comments on Treatment Progress:___________________________________________________________________________________________________ Counselor Required Medication Questions (must be asked at each session with a patient who is taking psychotropic medications): Providers must indicate that these questions are being asked and acted upon (as noted below) in order to qualify for continued authorizations. Are you taking your medications for the treatment of your mental health issue as prescribed by your medications provider? Yes___ No___ Are you finding that the medications continue to be helpful for you? Yes___ No___ Are you currently experiencing any unwanted symptoms that you believe could be related to your medications? Yes___ No___ Have you discussed any concerns related to your medications with your medications provider? Yes___ No___ If the patient indicates non-compliance/medication problems without communication with the medication provider, the therapist would be required to identify this as a treatment concern with the patient and request permission to fax/mail page 1 of this treatment plan along with a brief message noting the problem to the medication provider. Patient granted authorization for communication: Yes___ No___ Medication provider was sent notification: Yes___ No___ The patient is currently meeting with me: _____Weekly, _____2 x per month, _____Every 3 Weeks, _____Monthly, _____Less than Monthly CPT codes: _____90832, _____90833, _____90834, _____ 90836, _____90837, _____90838, _____90846, _____90847, _____90853, _____99213, _____99214, _____99215, _____Other:____________________________________________________________________________________ (Page 1 of this form may be used as faxed/mailed collaborative communication with other providers with your patients consent.) Quality of Care / Integrated Care Functions Please check the responses that apply: (Responses to all questions are required) The patient was advised of their rights to confidential care and educated about the benefits of an integrated approach to treatment on admission. The patient is aware that they may ask questions regarding confidentiality, integrated care and their treatment at any time. ____Yes ____No The patient was asked to sign releases to allow collaborative communication by phone/fax/mail with: Primary Care Provider Signed ___ Refused ___ Contacted in the last 6 months? Yes___ No___ Psychiatrist/Nurse Practitioner Signed ___ Refused ___ N/A___ Contacted in the last 6 months? Yes___ No___ Mental Health Professional Signed ___ Refused ___ N/A___ Contacted in the last 6 months? Yes___ No___ Substance Abuse Professional Signed ___ Refused ___ N/A___ Contacted in the last 6 months? Yes___ No___ Other Health Related Providers Signed ___ Refused ___ N/A___ Contacted in the last 6 months? Yes___ No___ (Page 1 of this form may be used as a faxed/mailed collaborative communication form with the patients consent) I notified the patients collateral providers at the start of treatment with me. Yes___ No___ I have attempted contact by phone/fax/mail with these providers as a recommended best practice every 6 months. Yes___ No___ I have requested patient feedback on the quality and direction of treatment each time we complete one of these treatment reports together. Yes ___ No ___ APA Continued Care Criteria 16.1-16.5/16.6 ___________________________________________________________________________________________________________________ ___________________________________________________________________________________________________________________ ___________________________________________________________________________________________________________________ ___________________________________________________________________________________________________________________ Number of Sessions Authorized:________ Date Range: ________________________________ ______________________________________________________________ ________________________________ Reviewer Signature/Title Date: PLEASE RETURN TREATMENT PLAN TO: BHCP, 110 FREE STREET, PORTLAND, ME 04101 Phone: 800-538-9698 Fax: (207) 761-3079 Website: BHCP.org Reviewer Comments: Do Not Write Below this Box; Administrative Use Only Goals /Continued Care / Outcome Planning Goal/ Expected Outcome/Prognosis: ___ Return to normal functioning ___ Expect improvement, anticipate less than normal functioning ___ Relieve acute symptoms, return to baseline functioning ___ Maintain current status, prevent deterioration What measurable indicator(s) are you using to determine that the patient has met their goals in treatment? ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ What stage of treatment is your patient in currently? _____ Initiation (Typically just starting treatment, assessment, goal setting, treatment plan development) _____ Active Treatment (Typically weekly/bi-weekly attendance and working on clear and achievable treatment plan goals) _____ Continued Care (Typically meeting monthly or less frequently, goals are directed toward protecting treatment gains) _____ Termination/Discharge Preparation (Typically moving toward closure of this treatment episode) Is your patient attending sessions regularly? Yes___ No___ If irregular attendance is an issue are you addressing this? Yes___ No___ N/A___ If you dont feel your patient is progressing in treatment, have you consulted others (Clinical Supervisor/Peers?) for assistance or considered referral to another provider? Yes___ No___ What is your estimated time frame for discharge from treatment or transfer to a continued care level for this patient? _______________ Are you discussing plans for community support/resources in your sessions as a preparation for discharge or transfer? Yes___ No___ Start Date of New Authorization: _________________ Provider Signature: _________________________________________ Date: __________________________ Signature of Provider: ______________________________________________________ Date: __________________________________  Yð靊w]YQMQMQMQM7*hhhYx5CJOJQJ\aJmH sH hmjhmUhM\3jhcB*CJKHUaJmHnHphtHu$jhoxB*CJKHUaJph$jh [B*CJKHUaJph$jhnB*CJKHUaJph$jhYxB*CJKHUaJph$jh BB*CJKHUaJph$jhrB*CJKHUaJphh'!$jh{2B*CJKHUaJph Yo  $1$a$gd'!1$gdH> $d1$a$gdr $dh1$a$gdr dh1$gdYl $1$a$gdYxdYmno  6 I P Z ] ^ q u } ʺʺʺʪʔ~nn^nKnn$hnhnCJOJQJaJmH sH h{2CJOJQJaJmH sH h(]CJOJQJaJmH sH *hYlhH>5CJOJQJ\aJmH sH *hYlh(]5CJOJQJ\aJmH sH hH>CJOJQJaJmH sH hnCJOJQJaJmH sH hYxCJOJQJaJmH sH !hYl5CJOJQJaJmH sH 'hYlhYx5CJOJQJaJmH sH    : ; L { 9 ; ࡝iUD!h(]>*CJOJQJaJmH sH 'h(]5>*CJOJQJ\aJmH sH +hh5B*OJQJ\mH phsH h5OJQJ\mH sH h(]5OJQJ\mH sH h(]h(]OJQJmH sH hH>CJOJQJaJmH sH h(]CJOJQJaJmH sH $hnhnCJOJQJaJmH sH hnCJOJQJaJmH sH hrCJOJQJaJmH sH  : ; p q X Y  M N >? $1$a$gd'!1$gdg1$gd'!; o q } W X Y   C kZG4G$h_e5CJOJQJ\aJmH sH $h(]5CJOJQJ\aJmH sH !h5CJOJQJaJmH sH 'h(]h(]5CJOJQJaJmH sH *h(]56CJOJQJ\]aJmH sH -h(]56>*CJOJQJ\]aJmH sH h(]h=:CJOJQJaJmH sH hgCJOJQJaJmH sH h)%CJOJQJaJmH sH hrCJOJQJaJmH sH h(]CJOJQJaJmH sH C J =>?VYCDJʺlXHʶ8h9d}CJOJQJaJmH sH h)%CJOJQJaJmH sH 'h(]5>*CJOJQJ\aJmH sH +hh(]5B*OJQJ\mH phsH +hh5B*OJQJ\mH phsH h5OJQJ\mH sH h(]5OJQJ\mH sH h(]hZICJOJQJaJmH sH h(]CJOJQJaJmH sH $h(]5CJOJQJ\aJmH sH $h_e5CJOJQJ\aJmH sH _1lm,-@ANO&d 1$P gdYx1$gdYx1$gd'!JM3 101;C#lmz~kU?U*hx!h(]5>*CJOJQJaJmH sH *hx!h/`5>*CJOJQJaJmH sH $hYx5>*CJOJQJaJmH sH hCJOJQJaJmH sH 0hXThZI>*B*CJOJQJaJmH phsH 0hXThZI>*B*CJOJQJaJmH phsH hZICJOJQJaJmH sH h)%CJOJQJaJmH sH h(]CJOJQJaJmH sH hi]CJOJQJaJmH sH ,-Nr?@AǴפׁq^H*hx!hi]5>*CJOJQJaJmH sH $hYx5>*CJOJQJaJmH sH hi]CJOJQJaJmH sH h(]CJOJQJaJmH sH $hwl%hYCJOJQJaJmH sH hwl%CJOJQJaJmH sH $hwl%h(]CJOJQJaJmH sH hYxCJOJQJaJmH sH $hwl%hwl%CJOJQJaJmH sH *hx!h(]5>*CJOJQJaJmH sH OP+\]^)/56<Cï{kk[k[kk[k[kH$hF_hh{CJOJQJaJmH sH hYlCJOJQJaJmH sH hh{CJOJQJaJmH sH $hYhh{CJOJQJaJmH sH hYCJOJQJaJmH sH !hi]6CJOJQJaJmH sH 'hWhhY6CJOJQJaJmH sH 3hI hh{5>*B*CJOJQJaJmH phsH !hYx>*CJOJQJaJmH sH !hi]>*CJOJQJaJmH sH OP^<"v  $1$a$gd'!1$^`gdwl%1$gdwl% $1$a$gdY & F1$gdF_ & F1$gdh{ $1$a$gdWh1$gd'!&d 1$P gdYxCMNZ_guںڧڔڄʄn^K7'hY4hY4CJOJQJ\aJmH sH $hYl5CJOJQJ\aJmH sH hY4CJOJQJaJmH sH *hF_hF_5CJOJQJ\aJmH sH hYlCJOJQJaJmH sH $hF_hYCJOJQJaJmH sH $hF_h=CJOJQJaJmH sH h0GCJOJQJaJmH sH hF_CJOJQJaJmH sH $hF_hh{CJOJQJaJmH sH $hF_hi]CJOJQJaJmH sH !" GvĪv\\\\E-hi]56B*CJOJQJaJmH phsH 3hwl%hI 56B*CJOJQJaJmH phsH 3hwl%hi]56B*CJOJQJaJmH phsH 3hwl%h=56B*CJOJQJaJmH phsH 3hwl%hY456B*CJOJQJaJmH phsH *hF_hF_5CJOJQJ\aJmH sH 'hY4hY4CJOJQJ\aJmH sH !hYlCJOJQJ\aJmH sH  19?@AFSTUZginuvw|躠p`pMp`pMp`>p`pMp`hwl%hwl%OJQJmH sH $hwl%hwl%CJOJQJaJmH sH hwl%CJOJQJaJmH sH h(]CJOJQJaJmH sH h(]OJQJmH sH 'hXTh(]5CJOJQJaJmH sH 3hWhhwV5B*CJOJQJ\aJmH phsH -ha(5B*CJOJQJ\aJmH phsH -hi]56B*CJOJQJaJmH phsH -hWh56B*CJOJQJaJmH phsH ?@hκκκκΥqd`Q`='h(]5>*CJOJQJ\aJmH sH h(]5OJQJ\mH sH h(]h(]>*OJQJmH sH 3hYh(]5B*CJOJQJ\aJmH phsH 3hYhYx5B*CJOJQJ\aJmH phsH (hwl%h(]56OJQJ\]mH sH 'hwl%h(]5CJOJQJaJmH sH 'hwl%hwl%5CJOJQJaJmH sH hwl%h(]5OJQJmH sH hwl%5OJQJmH sH ?@% s G!!"""""w#x#$$$C$D$$$1$gdF1$gdox1$gd' $1$a$gd'h , 8 C F e f !!!!!9!:!G!o!p!{!|!!!!!!!!!!!!""""""ȸȸȸȸȸȸȸȸȸȸ۸ۨ۸۸۸۸۸۸ےۂhoxCJOJQJaJmH sH *h(]56CJOJQJ\]aJmH sH h_eCJOJQJaJmH sH h{uCJOJQJaJmH sH $hwVh(]CJOJQJaJmH sH h(]CJOJQJaJmH sH 'h(]B*CJOJQJaJmH phsH ,"""""2#3#7#C#r#s#v#w#x######$$$$''"(jfVB'hchc5CJOJQJaJmH sH h{2CJOJQJaJmH sH h(]*h(]56CJOJQJ\]aJmH sH hFCJOJQJaJmH sH h5BCJOJQJaJmH sH hCJOJQJaJmH sH hGJCJOJQJaJmH sH h(]CJOJQJaJmH sH h%CJOJQJaJmH sH hoxCJOJQJaJmH sH hx!CJOJQJaJmH sH $-%.%%%&&&&&B'''-(i(j(((((c)))?*1$gdx! $1$a$gdx!p1$^p`gdr1$gdr $1$a$gd'1$gd'"(#(,(-(U(h(i(j((((((()) )#)')B)c))))?*<+³¤‘n^n^^n^Nh!CJOJQJaJmH sH hx!CJOJQJaJmH sH $hrhrCJOJQJaJmH sH hrCJOJQJaJmH sH $hx!5CJOJQJ\aJmH sH h!5OJQJ\mH sH h(]5OJQJ\mH sH h(]'hch{25CJOJQJaJmH sH 'hchc5CJOJQJaJmH sH !hB:5CJOJQJaJmH sH ?*@***;+<+}+~++b,,A-B--b...///20300000001$gd'1$gdx! $1$a$gd!<+g+q+++++++++, ,,,,,h,v,x,,--......///10000p`\h(]h{2CJOJQJaJmH sH hrCJOJQJaJmH sH h3CCJOJQJaJmH sH hCJOJQJaJmH sH hXTCJOJQJaJmH sH hGJCJOJQJaJmH sH h/`CJOJQJaJmH sH hZUPCJOJQJaJmH sH h)%CJOJQJaJmH sH h(]CJOJQJaJmH sH #000hM\hm21h:pM\/ =!"#$% j 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH R`R '!Normal)B*KHOJPJQJ_HmH phsH tH DA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List 44 hHeader  !4 4 hFooter  !PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] w: !K ((     w: !K (( (b Y ; C JCh""(<+00!"#%&'(*+-/0 O$?*0 $),.8@  (    Ng C"@@?   Hg C"@@?   Ng C"@@?   Ng C"@@?   Ng C"@@?   Ng C"@@?    N g C"@@?    N g C"@@?    N g C"@@?     N g C"@@?      N g C"@@?     N g C"@@?     N g C"@@?   VB  C D"? B S  ? (|(Mt|g(t(5t|5t|(nt|5(t |n(.6t |P(t |P( t|$P(T4t|"P($t | P(t |P("t|1(1t+ + + + +   (! ! (8*urn:schemas-microsoft-com:office:smarttagsCity=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName9*urn:schemas-microsoft-com:office:smarttagsplace Э((su  (51 6 wx 57  |%%%%b&j&((3333333333333333 Y  %PZ]qqu}:;Vbw{,,9;__oqWXXYY CJ>>??CDJM \ \ | | l m  + + , - = = N r ?@AFSTUZinuvw| !$-0,-78CFef889:ddop{}3vwwD- B B G G U U h <#&&'1((( Y  %PZ^qqu}:;Vbw{,,9;__oqWXXYY CJ!"%&/034>>??HI]^efklstwx'(CDJM  ! & ' ) * 3 7     $ % ' ( 1 6 \ \ | | # & k l m y z  + + , - = = N r ?@AFSTUZgnuvw|??@@,-78CFef889:ddop{}23vwwh i i j j <#p#~######### $ $$$a$b$q$r$v$w$$$$$%%%%&&&&&&&&&&'1((((((w *qOe]=D6'>D ^`o() ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.^`o() ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.^`5o() ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.w *Oe]='>                  v%g        hfJg3CMrB:!'!x!{")%wl%bj'a(f(`/iy2{2Y4|4o5`I5Y<8{}9=:=wC=H>B B5B[C}D0GZIGJLLZUP]VYI\i]P_F_/`h`ReWh{uYxa}9d}'acYlS;nQw:5OH&h~M\8oxmqXTF [_e dh{nFw k%wV(])Ok??A}v}I 'G (gRR@****(@UnknownG*Ax Times New Roman5Symbol3. *Cx ArialA. Arial Narrow7.@CalibriA$BCambria Math"h"I24(3QHP $P'!2!xx Rhonda L. DolleyTamara R Maher   Oh+'0@x    (08Rhonda L. DolleyNormalTamara R Maher2Microsoft Office Word@@enǣ@Hɣ@Hɣ՜.+,0 hp   MaineHealth  Title  !"#$%&'()*+,-./013456789:;<=>?@ABCDEFGHIJKLMNOPQRSTVWXYZ[\^_`abcdgRoot Entry FPɣi1Table21DWordDocument4bSummaryInformation(UDocumentSummaryInformation8]CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q